Alembic Limited which engaged in the
business of pharmaceuticals, real estate & power assets, today announced
that the company has approved the proposal for buy-back of over 1.2 crore fully
paid up equity shares of the Company, having face value of Rs. 2.00 each, for a
total consideration not exceeding Rs. 82.00 crore, representing up to 3.84% of
the total paid-up equity share capital of the company. The consideration
excludes transaction costs viz fees, brokerage, securities transaction tax, GST,
stamp duty and so on.
Meanwhile, the Alembic has reported a
standalone net profit of Rs 56.00 million in Dec 2017 quarter. The Company had
profit of Rs 7.00 million in the same quarter last year.
At 3.00 PM, Wednesday, the stocks of
Alembic were trading higher by 4.51% and 4.29% respectively, on NSE and BSE.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.